
Martik Pharma and Chemical Industries LLP
About Martik Pharma and Chemical Industries LLP
Data last updated:
Martik Pharma and Chemical Industries LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the process machinery and industrial equipment segment of the machinery and industrial equipment sector. It was incorporated on 08 February 2012 and has been in existence for over 14 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAA-7920.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Keya Mukherjee and Partha Sarathi Mukherjee.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat No – 8/E Pocket – A/1 Mayur Vihar Phase – III, Delhi, India – 110096.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹2.13 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹10.34 Lakh (net margin 4.8%) and EBITDA of ₹25.14 Lakh (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 40% over five years.
The LLP has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹1 Cr on record.
Company details
Contact details
Martik Pharma and Chemical Industries LLP's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No – 8/E Pocket – A/1 Mayur Vihar Phase – III, Delhi, India – 110096
- IndustryMachinery and Equipment, Process Machinery & Industrial Equipment
To see the full contact details of Martik Pharma and Chemical Industries LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Martik Pharma and Chemical Industries LLP
FY 2025 filings availableMartik Pharma and Chemical Industries LLP reported revenue of ₹2.13 Cr (up 18% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 18% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹10.34 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 4.8% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Martik Pharma and Chemical Industries LLP, buy the company report.
Designated partners of Martik Pharma and Chemical Industries LLP
Martik Pharma and Chemical Industries has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Keya Mukherjee | Designated Partner | 12 Jan 2020 | 6 Years 10 Months | Current |
| Partha Sarathi Mukherjee | Designated Partner | 08 Feb 2012 | 14 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2023 | 100763544 | Punjab National Bank | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Martik Pharma and Chemical Industries LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Martik Pharma and Chemical Industries LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Martik Pharma and Chemical Industries LLP has a workforce of 7 employees on its EPFO records as of Aug 2024, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 7 |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Martik Pharma and Chemical Industries LLP, buy the company report.
GST
No GST registration is on our record for Martik Pharma and Chemical Industries LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Martik Pharma and Chemical Industries LLP has 3 designated partner changes on record since 2012: 2 appointments and 1 cessation. The latest: Anil Bhan ceased to be Designated Partner on 12 Jan 2020.
Frequently asked questions
Martik Pharma and Chemical Industries is an active limited liability partnership based in Delhi, India. The LLP works in process machinery and industrial equipment, within the machinery and equipment industry. It was incorporated on 08 February 2012 (14+ years old) and is registered under LLPIN AAA-7920.
Martik Pharma and Chemical Industries has 2 current designated partners:
- Keya Mukherjee - Designated Partner
- Partha Sarathi Mukherjee - Designated Partner
The latest financial statements of Martik Pharma and Chemical Industries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Martik Pharma and Chemical Industries is AAA-7920. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Martik Pharma and Chemical Industries was incorporated on 08 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Bhan ceased to be Designated Partner on 12 Jan 2020. Keya Mukherjee was appointed as Designated Partner on 12 Jan 2020. Partha Sarathi Mukherjee was appointed as Designated Partner on 08 Feb 2012.
The registered office of Martik Pharma and Chemical Industries is at Flat No – 8E Pocket – A1 Mayur Vihar Phase – III, Delhi, India – 110096.
Martik Pharma and Chemical Industries operates in the machinery and equipment industry, in the process machinery and industrial equipment segment.
Martik Pharma and Chemical Industries has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Martik Pharma and Chemical Industries can be reached at its registered office: Flat No – 8E Pocket – A1 Mayur Vihar Phase – III, Delhi, India – 110096.

